Centerview Partners News
-
AstraZeneca Plc and Cubist Pharmaceuticals Inc. are among the suitors that made first-round bids for Optimer Pharmaceuticals Inc., the antibiotics maker weighing a sale, said people familiar with the matter.
-
Elan Corp. agreed to pay $1 billion for a share of the royalties on new drugs from Theravance Inc. as the Irish drugmaker tries to persuade shareholders to spurn a takeover offer by Royalty Pharma.
-
“We have to stop. I just pulled that note out of the blue,” said Audra McDonald on stage last night at Avery Fisher Hall. “I’m so proud of myself. Yay, Juilliard!”
-
Postmaster General Patrick Donahoe may soon be forced to choose which laws to flout to keep the barely solvent U.S. Postal Service running.
-
Theravance Inc., a biotechnology company seeking approval with GlaxoSmithKline Plc of the lung drug Breo, said it will split into two independent publicly traded companies. The shares rose as much as 13 percent.
-
J.C. Penney Co. is exploring ways to borrow against its real estate holdings to help raise cash, two people with knowledge of the situation said.
-
J.C. Penney Co. drew $850 million from its revolving credit facility as new Chief Executive Officer Myron Ullman hunts for cash in the wake of his predecessor’s failed overhaul.
-
Morgan Stanley’s Alex Glantz and Todd Davison, co-heads of media investment banking in North America, are among at least four bankers to leave the firm since bonuses were awarded in late February, people briefed on the matter said.
-
Fifth & Pacific Cos.’s Lucky Brand and Juicy Couture labels are attracting interest from private- equity firms and strategic buyers including VF Corp., said people with knowledge of the matter.
-
Centerview Partners LLP’s Lisbeth Barron , an investment banker to media companies such as Martha Stewart Living Omnimedia Inc ., is departing after two years to join Berenson & Co., another New York-based advisory boutique.
|
|
Centerview Partners Photos
Most Popular on Bloomberg
|
|
Centerview Partners Videos
|
|
Rate this Page